Hydrolytic Lysosomal Glucocerebroside-specific Enzyme

Name
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme
Accession Number
DBCAT003262
Description
Not Available
Drugs
DrugDrug Description
ImigluceraseA form of recombinant human beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.
AlgluceraseA form of recombinant beta-glucocerebrosidase enzyme used to replace the deficient endogenous enzyme in the treatment of Gaucher disease.
Velaglucerase alfaAn enzyme replacement therapy used for the long-term treatment of for pediatric and adult patients with type 1 Gaucher disease.
Taliglucerase alfaA hydrolytic lysosomal glucocerebroside specific enzyme, used for long term enzyme replacement therapy in patients with Type 1 Gaucher disease.
Drugs & Drug Targets
DrugTargetType
ImigluceraseGlucocerebrosidetarget
AlgluceraseGlucocerebrosidetarget
Velaglucerase alfaGlucosylceramidasetarget
Taliglucerase alfaGlucocerebrosidetarget